BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 5126169)

  • 41. Letter: Treatment of inoperable carcinoma of bronchus.
    Lancet; 1976 Jan; 1(7950):84-5. PubMed ID: 54599
    [No Abstract]   [Full Text] [Related]  

  • 42. [Attack treatment of broncho-pleuro-pulmonary cancer by polychemotherapy under the protection of phytohemagglutinin].
    Brocard H; Akoun G; Turpin G; Gendre JP
    Bull Mem Soc Med Hop Paris; 1967 Jan; 118(2):139-56. PubMed ID: 6061578
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy of bronchial carcinoma. Intermittent high-dosage polychemotherapy of bronchial carcinoma in combination with radical surgery for the prevention of recurrences and in primarily inoperable patients].
    Karrer K; Pridun N; Zwintz E
    Fortschr Med; 1973 Jan; 91(2):48-50. PubMed ID: 4121676
    [No Abstract]   [Full Text] [Related]  

  • 44. [Results of chemo-prophylaxis against recurrence after resection of pulmonary carcinomas with special consideration of their histological structure].
    Pridun N; Karrer K; Denck H
    Bronchopneumologie; 1977; 27(1):64-9. PubMed ID: 195679
    [No Abstract]   [Full Text] [Related]  

  • 45. [Polychemotherapy in patients following radical surgery for bronchial carcinoma].
    Karrer K; Pridun N; Denck H; Sighart H
    Osterr Z Onkol; 1977; 3(5-6):127-41. PubMed ID: 577010
    [No Abstract]   [Full Text] [Related]  

  • 46. [The chemotherapy of malignant tumors of the pleural cavity].
    Adelberger L
    Med Welt; 1967 Sep; 39():2296-305. PubMed ID: 5608841
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical experiences with Dibromdulcitol (DBD) in the treatment of cancer].
    Nyiredy G; Gévai E
    Bronches; 1971; 21(2):202-6. PubMed ID: 5126170
    [No Abstract]   [Full Text] [Related]  

  • 48. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Endoxan treatment in cases of inoperable bronchial carcinoma].
    Krzak J
    Gruzlica; 1975 Aug; 43(8):737-41. PubMed ID: 1158179
    [No Abstract]   [Full Text] [Related]  

  • 50. [Sequential chemotherapy and radiotherapy in inoperable squamous cell lung cancer (author's transl)].
    Arriagada R; Le Chevalier T; Sillet-Bach I
    Bull Cancer; 1981; 68(2):163-5. PubMed ID: 7016222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cyclophosphamide therapy of bronchial carcinoma].
    Baudach A; Berndt H; Gütz HJ; Prahl B; Rieche K; Setka J; Wolf M; Wolff G
    Med Klin; 1966 Apr; 61(15):586-92. PubMed ID: 5993430
    [No Abstract]   [Full Text] [Related]  

  • 52. Significance of postradiation bronchoscopical findings in the prognosis of bronchial carcinoma.
    Nikkanen V; Palojoki A
    Strahlentherapie; 1973 Dec; 146(6):639-43. PubMed ID: 4135130
    [No Abstract]   [Full Text] [Related]  

  • 53. [Results of single- and multiple-drug treatment of 183 cases of inoperable bronchopulmonary cancer].
    Valenti S
    Pol Tyg Lek; 1973 Apr; 28(14):519-23. PubMed ID: 4699459
    [No Abstract]   [Full Text] [Related]  

  • 54. [Survival of 17 patients with inoperable bronchial cancer treated with cytostatic agents and radiation in effective minimal doses].
    Rodriguez A; Schatz A; Rodriguez M; Cornejo J; Mendoza F; Santamaria J; Roa E; Rossi R
    Rev Med Chil; 1971 Aug; 99(8):560-5. PubMed ID: 5571330
    [No Abstract]   [Full Text] [Related]  

  • 55. [Trial of anticancerous polychemotherapy associating amethopterin, vinblastine and cyclophosphamide].
    Chauvergne J; Hoerni B; Simon G; Kressmann MP
    Bord Med; 1971 May; 4(5):1531-44. PubMed ID: 5569949
    [No Abstract]   [Full Text] [Related]  

  • 56. [Trends in medico-surgical treatment of primary broncho-pulmonary neoplasms].
    Le Brigand H; Merlier M; Rojas-Miranda A; Levasseur P
    Presse Med (1893); 1970 Jul; 78(33):1475-80. PubMed ID: 5428993
    [No Abstract]   [Full Text] [Related]  

  • 57. [Preliminary evaluation of intermittent polychemotherapy in high doses for prevention of recurrence after radical operation of lung cancer (author's transl)].
    Karrer K; Pridun N; Zwintz E
    Arch Geschwulstforsch; 1973; 42(4):316-23. PubMed ID: 4802890
    [No Abstract]   [Full Text] [Related]  

  • 58. [Progress observations in patients with inoperable lung tumors during treatment with a combined internal therapy (alkylating agent and endogenous polypeptid)].
    Klose G; Below R
    Krebsarzt; 1969; 24(2):80-7. PubMed ID: 5802199
    [No Abstract]   [Full Text] [Related]  

  • 59. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z; Dimopoulos MA; Kostakopoulos A; Karayiannis A; Sofras F; Zervas A; Giannopoulos A; Dimopoulos C
    J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy of the small cell bronchial carcinoma].
    Bruntsch U
    MMW Munch Med Wochenschr; 1980 Sep; 122(37):1248-52. PubMed ID: 6775205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.